Gynomunal® is a vaginal moisturising gel containing natural hop extract – a source of phytoestrogens – long thought to be beneficial for gynaecological conditions.
Gynomunal® also contains Vitamin E which has anti-oxidant and anti-inflammatory properties and helps wound healing and tissue regeneration.
Gynomunal®’s liposomal formulation also contains hyaluronic acid – a naturally occurring substance – that provides a protective film for damaged tissues as well as providing long-lasting hydration.
Vaginal dryness is very common – up to 55% of menopausal women are affected by it. Vaginal dryness is usually the first symptom of Atrophic Vaginitis – thinning, dryness and inflammation of a woman’s vaginal tissues. These tissues normally make a clear lubricating fluid to keep them healthy and supple but if this doesn’t happen vaginal dryness occurs. The main cause of vaginal dryness is a decrease in oestrogen hormone levels – e.g. at the menopause. It is also common in women immediately after childbirth or during breastfeeding. It can occur in women taking contraceptives, at times of stress or as a result of radiotherapy or chemotherapy.
Common symptoms of vaginal dryness are burning, itching or soreness of the vagina. Vaginal bleeding (spotting) may also occur. You may first notice vaginal dryness as a lack of natural lubrication during sexual intercourse. Vaginal dryness is usually the first symptom of Atrophic Vaginitis – thinning, dryness and inflammation of a woman’s vaginal tissues. These tissues normally make a clear lubricating fluid to keep them healthy and supple but if this doesn’t happen vaginal dryness occurs. Up to about 50% of women with symptoms describe them as moderate or severe.
Vaginal dryness varies in duration depending on the underlying cause and severity. Symptoms of vaginal dryness usually appear within 12 months of the menopause. However, symptoms can take up to 3 years or more after the menopause to develop. Unlike other symptoms of the menopause, such as hot flushes, that may resolve over time, Atrophic Vaginitis does not resolve spontaneously and can progressively worsen. As about one-third of a woman’s life is after menopause its important to diagnose and treat any problems.
Whilst vaginal burning, itching and pain are often due to vaginal dryness they might be caused by infection, irritation or other causes. It is important to discuss this with your Doctor before starting treatment.
The most common symptoms of vaginal dryness include itching, burning and soreness. The cause of these can also lead to many women having some degree of urinary urgency. 80% of women with such symptoms report a decrease in sexual desire and satisfaction. Persistent vaginal dryness can lead to pain during sexual intercourse (Dyspareunia). Up to 40% of women are affected by dyspareunia.
As few as 10% of women will talk to their Doctor about vaginal dryness because they are either too embarrassed to discuss it or they consider it to be a natural ageing process that is not treatable. Your Doctor can advise on the best treatment for you. Gynomunal® is a non-hormonal vaginal moisturising gel containing natural hop extract and Vitamin E. It has been specifically formulated for vaginal use and shown to be gentle and soothing. Importantly, unlike some products, Gynomunal® has been clinically proven to provide fast relief from the symptoms of vaginal dryness. Its long-lasting effects help restore vaginal moisture and promote the natural healing process.
Gynomunal® is a vaginal moisturising gel containing natural hop extract – a source of phytoestrogens – long thought to be beneficial for gynaecological conditions. Gynomunal® also contains Vitamin E which has anti-oxidant and anti-inflammatory properties and helps wound healing and tissue regeneration. Gynomunal®’s liposomal formulation also contains hyaluronic acid – a naturally occurring substance – that provides a protective film for damaged tissues as well as providing last-lasting hydration. The effectiveness of Gynomunal® has been demonstrated in clinical studies. Gynomunal® has been developed as a Class IIa Medical Device. Gynomunal® is available without prescription in the UK, Switzerland and Liechtenstein.
Gynomunal® contains: Hop extract (Humulus lupulus), tocopherol acetate (Vitamin E), purified water, propylene glycol, denatured ethanol, soya lecithin (E322), carbomer, sodium hydroxide, sodium methyl-4-hydroxybenzoate (E219), cholesterol, imidazolidinylurea, sodium edetate, hyaluronic acid, sodium propyl-4-hydroxybenzoate (E217).
A clinical study of 100 post-menopausal women who used Gynomunal® showed rapid relief of vaginal dryness within one-week and a 58% improvement after one month. The clinical study also showed significant and rapid relief from symptoms of itching, burning and pain as well as for inflammation, swelling and rash. With continued use there was complete relief from vaginal dryness. Gynomunal® has been shown to be safe for long-term use. The publication can be downloaded here.
In a separate study of 85 women it was shown that premenopausal women had measured vaginal moisture values of 93 RH% or 95 RH% depending on the phase of their cycle. Postmenopausal women, before starting treatment, were shown to have measured vaginal moisture values of 69 RH%. Gynomunal led to a 37% increase in vaginal moisture after only 30 minutes and to a long-lasting improvement of vaginal dryness and its symptoms. The publication can be downloaded here.
Use Gynomunal® once every day for the first seven days and then twice a week after that. There is enough gel for 20 doses in a tube of Gynomunal® 50 ml i.e. enough for up to 10 weeks treatment if you have already used Gynomunal® daily for more than a week.
Gynomunal® is available on prescription. Gynomunal® can also be bought without prescription at your local pharmacy or on this website. Gynomunal® is a vaginal moisturising gel containing natural hop extract – a source of phytoestrogens – long thought to be beneficial for gynaecological conditions. Gynomunal® also contains Vitamin E which has anti-oxidant and anti-inflammatory properties and helps wound healing and tissue regeneration. Gynomunal®’s liposomal formulation also contains hyaluronic acid – a naturally occurring substance – that provides a protective film for damaged tissues as well as providing last-lasting hydration.
If you are a pharmacy and wish to order Gynomunal® from a pharmaceutical wholesaler then you can do so from:
Order using the AAH product code GYN36P for Gynomunal 50 ml. If you have issues ordering on your pharmacy system then call AAH customer care on 0844 5618899 for assistance.
Ambe Medical Group
Ambe House, Commerce Way,
Edenbridge, Kent, TN8 6ED.
Gynomunal 50 ml 382-4943
If you are an NHS Clinic / Pharmacy then Gynomunal® is available through NHS Supply Chain. Please refer to the following ordering information:
Product: Gynomunal® 50 ml
NHS NPC: DMB103
SUPPLIER MPC: 316840030
Base Description: Female Creams / Ointments
Secondary Description: Vaginal moisturiser 50ml tube with 5 applicators
Gynomunal® is available with or without prescription in the UK, as well as in Switzerland and Liechtenstein. Customers in the UK can also order Gynomunal® on this website. Customers in Switzerland and Liechtenstein can order Gynomunal® at www.gynomunal.ch. The product carton contains full instructions for use. We are unable to accept returns of unused product.
You can choose which delivery option you want after you have completed the Paypal login page – your order will only be processed after you select the delivery option you want on the following page. Orders will only be dispatched to the address confirmed by Paypal. If your billing and dispatch addresses are different please ensure that you correct this within the Paypal instruction. As dispatch uses Royal Mail we are unable to redirect deliveries if you provide an incorrect shipping address.
If you are ordering at least one Gynomunal 50 ml pack then First Class Royal Mail delivery is free. For other orders you will be offered shipping rates at checkout. If you require additional shipping options please contact us at firstname.lastname@example.org
Orders placed before 2pm (Monday to Friday excluding Public Holidays) will normally be despatched the same day.
If you require more than 8 units of product in one delivery then please contact us at email@example.com to arrange shipping rates.
For further information on Royal Mail delivery and conditions see royalmail.com
C&D PIP code: Gynomunal 50 ml 382-4943
Customers in Switzerland and Liechtenstein can buy Gynomunal® at good pharmacies or order at gynomunal.ch
Instructions for Use Download
You can download the full Gynomunal® Instructions for Use here
Always read the instruction leaflet before using Gynomunal® for the first time. Whilst vaginal burning, itching and pain are often due to vaginal dryness they might be caused by infection, irritation or other causes. It is important to discuss this with your Doctor before starting treatment.
Store Gynomunal® between 15-30°C.
Gynomunal® is hormone-free.
Gynomunal® is gynaecologically tested.
Gynomunal® can be used in conjunction with HRT (Hormone Replacement Therapy).
Gynomunal® is non-irritant.
Gynomunal® is non-sensitising.
Gynomunal® is fragrance free.
Gynomunal® is latex free.
Do not use Gynomunal® if you are hypersensitive to any component in the product.
If you have a vaginal infection consult your Doctor before using Gynomunal®.
Do not use vaginal contraceptives while using Gynomunal®.
Do not use Gynomunal® while you are on vaginal drugs or using a vaginal medical device.
Gynomunal® (gel and applicator) is intended for individual use in adults only and must not be shared with other people.
Do not use the vaginal applicator if you are pregnant. You can apply the gel using your fingers instead – see the instructions.
Do not use the applicator if it is damaged or dirty.
Gynomunal® is compatible with natural rubber latex and polyisoprene condoms. It is not compatible with polyurethane condoms.
Keep out of the sight and reach of children.
Do not swallow.
Barlow DH, Cardozo LD, Francis RM, et al. Urogenital ageing and its effect on sexual health in older British women. BJOG 1997;104:87–91.
Goldstein I, Alexander JL. Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women. J Sex Med. 2005;2(Suppl 3):154-165.
Goldstein I. Recognizing and treating urogenital atrophy in postmenopausal women. J Women’s Health. 2010;19(3):425-432.
Ghumman S. Atrophic Vaginitis: Diagnosis and Treatment. J South Asian Feder Menopause Soc 2013; 1(1):4-12.
Johnston SL, Farrell SA. The detection and management of vaginal atrophy. SOGC Clinical Practice Guidelines. No. 145, May 2004.
Kingsberg SA, Kellogg S, Krychman M. Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy. International Journal of Women’s Health, 2009:1 105-111.
Mac Bride MB, Rhodes DJ, Shuster LT. Vulvovaginal Atrophy. Mayo Clin Proc. January 2010;85(1):87-94 DOI:10.4065/mcp.2009.0413.
NHS Direct. Accessed 30 September 2013 http://www.nhsdirect.nhs.uk/~/media/Selfcare/FemaleSexualHealth/VaginalDryness.ashx
Morali G, Polatti F, Metelitsa EN, Mascarucci P, Magnani P, Marrè GB. Open, non-controlled clinical studies to assess the efficacy and safety of a medical device in form of gel topically and intravaginally used in postmenopausal women with genital atrophy. Arzneimittelforschung. 2006;56(3):230-8.
Santos I, Clissold S. Urogenital disorders associated with oestrogen deficiency: The role of promestriene as topical oestrogen therapy. Gynecological Endocrinology, 2010, 26, 644-651. DOI:10.3109/09513591003767948.
Suckling JA, Kennedy R, Lethaby A, Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD001500. DOI:10.1002/14651858.CD001500.pub2.
Van Geelen JM, van de Weijer PH, Arnolds HT. Urogenital symptoms and resulting discomfort in non-institutionalized Dutch women aged 50–75 years. Int Urogynecol J Pelvic Floor Dysfunct 2000;11:9–14.
Sparavigna A, Tenconi B, De Ponti I, Bulgheroni A, Scarci F. A controlled, randomized, open label study in postmenopausal women to assess the safety and the efficacy of a vaginal moisturizer: An instrumental approach. Open Journal of Obstetrics and Gynecology. 2013;3:395-399 OJOG doi:10.4236/ojog.2013.34073.
Problems with Gynomunal®
If you have any problems with Gynomunal® or any issues that you think might be due to Gynomunal® then please email us immediately at firstname.lastname@example.org or contact us through our website www.cederberg.ch
Gynomunal® is distributed in the UK, Switzerland and Liechtenstein by Cederberg GmbH.
Cederberg GmbH is an innovative Swiss healthcare company founded in 2008 and is headquartered in Basel, Switzerland.
Cederberg specialises in the development and commercialisation of patent-protected medicines and medical devices that deal with unmet medical needs.
Cederberg also markets two medicines that are only available on prescription through Cederberg in Switzerland and Liechtenstein.
Cederberg is a Swiss registered company and has been inspected and approved by the Swiss healthcare regulatory authority, Swissmedic.
For more information on Cederberg please contact us at email@example.com or visit our website www.cederberg.ch
Company number: CH-280.4.012.295-9
UK VAT number: 139 6243 00
CH VAT number: CHE-114.617.064 MWST
Gynomunal® is a Class IIa Medical Device.
Cederberg GmbH is the exclusive distributor of Gynomunal® in the UK, Switzerland and Liechtenstein.
Manufacturer: Polichem SA, Via Angelo Maspoli 11, 6850 Mendrisio, Switzerland.
Terms and Conditions for Freebie Friday run via Twitter
• Entry to our Freebie Friday promotion run via Twitter is only open to UK residents aged 18 and over.
• No purchase is necessary to enter.
• To enter, you must follow our product related Twitter account and retweet our Freebie Friday message by the relevant closing date and time. You need to follow us so that we can send a direct message to you requesting a delivery address for the prize. You may then subsequently unfollow if you wish.
• There is a limit of one entry per person.
• Entries that are not in accordance with these terms and conditions will not be accepted. Entries made through agents, third parties, organised groups or any entry duplication method will not be accepted.
• The prize(s) will be set out in the relevant promotional Tweet.
• The winner(s) will be selected at random within 7 days of the closing date and notified by direct message.
• The winner(s) must claim their prize(s) by providing a delivery address within 14 days of notification. If they do not do so, then we reserve the right to offer the prize to an alternative winner on a subsequent occasion.
• Any decision regarding eligibility to take part in the promotion or the result of the promotion will be made by us and will be final. No correspondence will be entered into. We accept no responsibility for entries that are incomplete, delayed, lost, or otherwise not received or acceptable due to failure or non-availability of twitter.com or any other reason.
• There is no cash alternative to the prize(s).
• Images used are for visual purposes only. Alternative products may be substituted for the items shown. We reserve the right (but are not obliged) to substitute an alternative to any of the prizes of equal or greater value should circumstances make this necessary.
• We reserve the right to delay, postpone or cancel the promotion.
• Entry implies acceptance of these terms and conditions and Twitter’s terms of service. By accepting these terms and conditions entrants accept that, in the event that they win, their Twitter username and the county to which the prize was sent to may be disclosed publicly.
• A list of winners’ names and the counties to which the prizes were sent will be available on request within 28 days after the winners’ have claimed the prize(s) by sending an email to firstname.lastname@example.org
• By entering the promotion, all entrants agree that we will use their personal data for the sole purpose of administering this promotion.
• The promotion and these terms and conditions are subject to English law. Any disputes must be referred to the English Courts.
Promoter: Cederberg GmbH, Basel, Switzerland 4102.
© 2020 Gynomunal